Bioequivalent test items flock to specific ingredients.

It was found that the drugs completed with its bio-equivalent test and to be booked on the Common Prescription List with priority had been concentrated on specific ingredients, which may trigger a severe competition in the market and restrict chances for pharmacists to substitute in their dispensing.

The tests for some products have gone worthless in spite of their multi-million won spending...